MaxCyte, Inc. (MXCT) Earnings Call Transcripts

25 earnings calls from January 2021 to May 12, 2026

NasdaqGS GB Health Care Life Sciences Tools and Services

About MaxCyte, Inc.

MaxCyte, Inc. (MXCT) is a publicly listed company in the Life Sciences Tools and Services industry, within the Health Care sector. It trades on NasdaqGS and is based in GB. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning January 20, 2021 to May 12, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 25 MaxCyte, Inc. earnings call transcripts on record, spanning January 20, 2021 to May 12, 2026. Based on this history, MaxCyte, Inc. reports quarterly. The most recent call on file is dated May 12, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
MXCT
Exchange
NasdaqGS
Country
GB
Sector
Health Care
Industry
Life Sciences Tools and Services
Calls on record
25
First call
January 20, 2021
Most recent
May 12, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2026 May 12, 2026 Read transcript
Q4 FY2025 Mar 24, 2026 Read transcript
Q3 FY2025 Nov 12, 2025 Read transcript
Q2 FY2025 Aug 6, 2025 Read transcript
Q1 FY2025 May 7, 2025 Read transcript
Q4 FY2024 Mar 11, 2025 Read transcript
Q3 FY2024 Nov 6, 2024 Read transcript
Q2 FY2024 Aug 6, 2024 Read transcript
Q1 FY2024 May 7, 2024 Read transcript
Earnings Calls Mar 12, 2024 Read transcript
Q3 FY2023 Nov 8, 2023 Read transcript
Q3 FY2023 Oct 4, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 10, 2023 Read transcript
Q4 FY2022 Mar 15, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Company Conference Presentations Sep 13, 2022 Read transcript
Q2 FY2022 Aug 10, 2022 Read transcript
Company Conference Presentations May 11, 2022 Read transcript
Q1 FY2022 May 9, 2022 Read transcript
Q4 FY2021 Mar 22, 2022 Read transcript
Shareholder/Analyst Calls Feb 8, 2022 Read transcript
Q3 FY2021 Nov 10, 2021 Read transcript
Q2 FY2021 Sep 13, 2021 Read transcript
Sales/Trading Statement Calls Jan 20, 2021 Read transcript